KR102637759B1 - 탄산 무수화효소 억제제로서의 아릴 설폰아마이드 화합물 및 이의 치료상 용도 - Google Patents
탄산 무수화효소 억제제로서의 아릴 설폰아마이드 화합물 및 이의 치료상 용도 Download PDFInfo
- Publication number
- KR102637759B1 KR102637759B1 KR1020187003119A KR20187003119A KR102637759B1 KR 102637759 B1 KR102637759 B1 KR 102637759B1 KR 1020187003119 A KR1020187003119 A KR 1020187003119A KR 20187003119 A KR20187003119 A KR 20187003119A KR 102637759 B1 KR102637759 B1 KR 102637759B1
- Authority
- KR
- South Korea
- Prior art keywords
- benzenesulfonamide
- oxoimidazolidin
- amino
- cancer
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187636P | 2015-07-01 | 2015-07-01 | |
| US62/187,636 | 2015-07-01 | ||
| PCT/US2016/040736 WO2017004543A1 (en) | 2015-07-01 | 2016-07-01 | Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20180023990A KR20180023990A (ko) | 2018-03-07 |
| KR102637759B1 true KR102637759B1 (ko) | 2024-02-19 |
Family
ID=56411955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020187003119A Active KR102637759B1 (ko) | 2015-07-01 | 2016-07-01 | 탄산 무수화효소 억제제로서의 아릴 설폰아마이드 화합물 및 이의 치료상 용도 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10562859B2 (https=) |
| EP (1) | EP3317255B1 (https=) |
| JP (1) | JP6795525B2 (https=) |
| KR (1) | KR102637759B1 (https=) |
| CN (1) | CN107922345B (https=) |
| AU (1) | AU2016287587B2 (https=) |
| BR (1) | BR112018000065B1 (https=) |
| CA (1) | CA2991168C (https=) |
| IL (1) | IL256527B (https=) |
| MX (1) | MX387267B (https=) |
| WO (1) | WO2017004543A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2931533T3 (es) * | 2017-04-05 | 2022-12-30 | Harvard College | Compuesto macrocíclico y usos del mismo |
| KR20210000564A (ko) | 2019-06-25 | 2021-01-05 | 공주대학교 산학협력단 | 신규 아만타딘 유도체 화합물 및 이의 용도 |
| CN111233786B (zh) * | 2020-02-04 | 2021-11-26 | 中国人民解放军军事科学院军事医学研究院 | 含五元杂环的苯磺酰胺类化合物及其制备方法和用途 |
| JP7514036B2 (ja) * | 2020-06-02 | 2024-07-10 | イェディテペ・ウニヴェルシテシ | 癌の治療のための炭酸脱水酵素ＩＸ阻害剤としての２－（３－（２－メチル－６－（ｐ－トリル）ピリジン－３－イル）ウレイド）ベンゼンスルホンアミドおよびその誘導体 |
| TR202014185A2 (tr) * | 2020-09-08 | 2022-03-21 | Anadolu Ueniversitesi | BAZI YENİ 4-(2-((5-(SÜBSTİTÜEAMİNO)-1,3,4-TİYADİAZOL-2-İL)TİYO)ASETİL)BENZENSÜLFONAMİD TÜREVLERİ ve SÖZ KONUSU TÜREVLERİN SENTEZİ İÇİN BİR YÖNTEM |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130012485A1 (en) * | 2006-12-22 | 2013-01-10 | Baeschlin Daniel Kaspar | Organic compounds |
| WO2013023274A1 (en) | 2011-08-16 | 2013-02-21 | Universite Laval | Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003013655A2 (en) * | 2001-08-10 | 2003-02-20 | Pharmacia Corporation | Carbonic anhydrase inhibitors |
| WO2012021963A1 (en) | 2010-07-09 | 2012-02-23 | Metasignal Therapeutics Inc. | Novel sulfonamide compounds for inhibition of metastatic tumor growth |
-
2016
- 2016-07-01 KR KR1020187003119A patent/KR102637759B1/ko active Active
- 2016-07-01 US US15/743,601 patent/US10562859B2/en active Active
- 2016-07-01 JP JP2017568244A patent/JP6795525B2/ja active Active
- 2016-07-01 WO PCT/US2016/040736 patent/WO2017004543A1/en not_active Ceased
- 2016-07-01 CA CA2991168A patent/CA2991168C/en active Active
- 2016-07-01 AU AU2016287587A patent/AU2016287587B2/en active Active
- 2016-07-01 MX MX2018000175A patent/MX387267B/es unknown
- 2016-07-01 BR BR112018000065-5A patent/BR112018000065B1/pt active IP Right Grant
- 2016-07-01 CN CN201680046227.7A patent/CN107922345B/zh active Active
- 2016-07-01 EP EP16738988.1A patent/EP3317255B1/en active Active
-
2017
- 2017-12-24 IL IL256527A patent/IL256527B/en active IP Right Grant
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130012485A1 (en) * | 2006-12-22 | 2013-01-10 | Baeschlin Daniel Kaspar | Organic compounds |
| WO2013023274A1 (en) | 2011-08-16 | 2013-02-21 | Universite Laval | Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer |
Non-Patent Citations (2)
| Title |
|---|
| Bioorganic & Medicinal Chemistry Letters, (2014) Volume 24, Issue 7, pp. 1776-1779 |
| Journal of Medicinal Chemistry, (2011) Vol. 54, 1896-1902 |
Also Published As
| Publication number | Publication date |
|---|---|
| US10562859B2 (en) | 2020-02-18 |
| WO2017004543A1 (en) | 2017-01-05 |
| BR112018000065A2 (pt) | 2018-09-11 |
| CN107922345B (zh) | 2021-03-23 |
| US20180201584A1 (en) | 2018-07-19 |
| MX387267B (es) | 2025-03-18 |
| MX2018000175A (es) | 2018-03-26 |
| JP2018519332A (ja) | 2018-07-19 |
| IL256527A (en) | 2018-02-28 |
| HK1248228A1 (en) | 2018-10-12 |
| KR20180023990A (ko) | 2018-03-07 |
| IL256527B (en) | 2021-04-29 |
| JP6795525B2 (ja) | 2020-12-02 |
| CA2991168A1 (en) | 2017-01-05 |
| AU2016287587B2 (en) | 2020-04-30 |
| CA2991168C (en) | 2022-04-26 |
| EP3317255A1 (en) | 2018-05-09 |
| AU2016287587A1 (en) | 2018-01-25 |
| CN107922345A (zh) | 2018-04-17 |
| BR112018000065B1 (pt) | 2023-11-07 |
| EP3317255B1 (en) | 2021-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009331179B2 (en) | Novel bicyclic heterocyclic compound | |
| KR102637759B1 (ko) | 탄산 무수화효소 억제제로서의 아릴 설폰아마이드 화합물 및 이의 치료상 용도 | |
| AU2014353006B2 (en) | Quinazoline derivatives as TAM family kinase inhibitors | |
| CN104936944A (zh) | 作为酪氨酸激酶抑制剂的吲哚满酮衍生物 | |
| US20250041429A1 (en) | Compound having btk protein degradation activity, and medical uses thereof | |
| CA3090233A1 (en) | Compounds for inhibiting tnik and medical uses thereof | |
| CN111410618A (zh) | 具有己糖激酶2抑制活性的化合物及用途 | |
| KR20090116716A (ko) | 칸나비노이드-ｃｂ1 길항작용과 아세틸콜린에스테라제 억제가 조합된 화합물 | |
| WO2006003881A1 (ja) | 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤 | |
| KR20210151887A (ko) | 화합물, 조성물 및 방법 | |
| US20230399332A1 (en) | IMIDAZO[1,2-a]PYRAZINE OR PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF | |
| KR101980180B1 (ko) | 그렐린 수용체 작용제로서의 세린 유도체 | |
| HK1248228B (en) | Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use | |
| HK1228287B (zh) | 作为tam家族激酶抑制剂的喹唑啉衍生物 | |
| US9242938B2 (en) | Glycine reuptake inhibitor and use thereof | |
| HK1228287A1 (en) | Quinazoline derivatives as tam family kinase inhibitors | |
| HK1143587A (en) | Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20180131 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20210525 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20230925 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20231226 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20240213 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20240214 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration |